Demand for screening has exceeded the initial workload estimates and feedback from users found that the current screening method had an unacceptable turn around time, with an impact on patient isolation and potential for spread of CPE between patients due to delay in recognition of status.
In response to this and since the launch of several new products onto the market in 2017, Microbiology at NWLP have conducted an extensive evaluation of products currently available, testing time to result, accuracy, reproducibility, technical skill level required, cost and ease of workflow. A new testing pathway is currently being introduced with a live test of patient samples due to start imminently.
For further information, click on this summary of CPE lab detection updates